Skip to main content
. Author manuscript; available in PMC: 2023 Feb 13.
Published in final edited form as: J Alzheimers Dis. 2022;85(1):73–90. doi: 10.3233/JAD-215022

Table 6.

Primary and Secondary Self-report Outcome Measures for the EMMA-only and partnered Condition (standard deviations in parentheses)

Time
Outcome Measure Pre-training Post-training Post-training
Month 1
Post-training
Month 3

QOL-AD
 Partnered 38.7 (6.1) 38.6 (6.9) 39.2 (6.1) 38.5 (7.3)
 EMMA-only 38.1 (5.3) 38.9 (4.9) 39.0 (4.5) 39.1 (4.8)
IADL-Ca
 Partnered 2.0 (0.7) 2.1 (0.9) 1.9 (0.6) 1.9 (0.8)
 EMMA-only 1.9 (0.5) 2.0 (0.6) 2.3 (0.8) 2.0 (0.8)
CSE
 Partnered 86.8 (20.5) 94.2 (19.1) 93.5 (19.1) 95.5 (18.4)
 EMMA-only 91.7 (14.3) 95.4 (14.7) 97.2 (18.4) 94.0 (20.9)
SWLS
 Partnered 22.9 (8.4) 25.6 (7.6) 24.7 (8.4) 25.2 (6.5)
 EMMA-only 25.3 (7.2) 26.9 (5.6) 24.3 (6.2) 24.8 (7.2)

EMMA, Electronic Memory and Management Aid; QOL-AD, Quality of Life – Alzheimer’s Disease; IADL-C, Instrumental Activities of Daly Living –Compensation; CSE, Coping Self-Efficacy Scale; SWLS, Satisfaction with Life Scale. Follow-up month 2 data was not included because prompts were removed for the partnered condition.

a

A lower score represents better self-reported everyday functioning.